NCT06853678 2025-03-03Second-line Immunotherapy for ES-SCLCTianjin Medical University Cancer Institute and HospitalPhase NA Recruiting30 enrolled
NCT04047953 2023-04-05Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric AdenocarcinomaPeking University Cancer Hospital & InstitutePhase NA Recruiting95 enrolled